SupremeToday Landscape Ad
Back
Next
Judicial Analysis Court Copy Headnote Facts Arguments Court observation
Listen Audio Icon Pause Audio Icon
judgment-img

2023 Supreme(Del) 5622

IN THE HIGH COURT OF DELHI AT NEW DELHI
C. Hari Shankar, J.
Vifor International Ltd. & Anr. - Appellants
Versus
Aishwarya Health Care Private Limited & Ors. - Respondents
CS(COMM) 167 of 2023
Decided On : 24-11-2023

Advocates appeared:
Mr. Pravin Anand, Ms. Vaishali Mittal, Mr. Siddhant Chamola and Ms. Gitanjali Sharma, Advocates, for the Plaintiffs.
Mr. Ashutosh Kumar, Mr. Swarnil Dey and Mr. Vivek Tiwari, Advocates, for the Defendants.

IMPORTANT POINT
The court's decision was based on the lack of evidence of infringement by the defendants before the expiry of the patent.

Headnote:

Patent Infringement - FERRIC CARBOXYMALTOSE - The court found that the defendants did not infringe the plaintiffs' registered patent as the compound FERRIC CARBOXYMALTOSE was not manufactured or sold prior to the expiry of the patent.

Fact of the Case:

The plaintiffs alleged that the defendants infringed their registered patent for the compound FERRIC CARBOXYMALTOSE. However, the defendants stated that they did not manufacture or sell the product before the patent expired.

Finding of the Court:

The court found that the defendants did not infringe the plaintiffs' registered patent as the compound FERRIC CARBOXYMALTOSE was not manufactured or sold prior to the expiry of the patent. The court disposed of the suit and granted the plaintiffs a refund of the court fee deposited.

Issues: The main issue was whether the defendants infringed the plaintiffs' registered patent for FERRIC CARBOXYMALTOSE.

Ratio Decidendi: The court's decision was influenced by the fact that the defendants did not manufacture or sell the compound FERRIC CARBOXYMALTOSE before the expiry of the patent.

Final Decision: The suit was disposed of, and the plaintiffs were granted a refund of the court fee deposited.

JUDGMENT (Oral)

C. HARI SHANKAR, J.

CS(COMM) 167/2023

1.  The grievance of the plaintiffs in this suit is that the defendants are infringing the plaintiffs' registered patent IN 221536 (IN'536) which claimed the compound FERRIC CARBOXYMALTOSE, under the brand name FEROCOSE FCM. Accordingly, the plaintiffs seek a decree of permanent injunction against the defendants from infringing the plaintiffs' registered patent IN 221536 and from manufacturing and clearing in the market FERRIC CARBOXYMALTOSE, which is subject matter of the suit patent.

2.  During the pendency of these proceedings IN'536 has expired on 20 October 2023.

3.  The defendants have filed an affidavit dated 22 November 2023 deposing, on oath, that neither have they manufactured nor sold any product comprising the compound FERRIC CARBOXYMALTOSE, prior to the expiry of the suit patent.

4.  In that view of the matter, Mr. Siddhant Chamola, learned Counsel for the plaintiffs does not press the present suit any further. He, however, prays that the court fees deposited by the plaintiffs may be refunded.

5.  The suit stands disposed of accordingly.

6.  The plaintiffs shall be entitled to refund of the court fee deposited by them.

I.A. 5770/2023 (Order XXXIX Rules 1 and 2 the CPC) and I.A. 5771/2023 (Order XI Rule 2 the CPC)

7.  These applications do not survive for consideration and stand disposed of.

Click Here to Read the rest of this document
1
2
3
4
5
6
7
8
9
10
11
SupremeToday Portrait Ad
supreme today icon
logo-black

An indispensable Tool for Legal Professionals, Endorsed by Various High Court and Judicial Officers

Please visit our Training & Support
Center or Contact Us for assistance

qr

Scan Me!

India’s Legal research and Law Firm App, Download now!

For Daily Legal Updates, Join us on :

whatsapp-icon Back to top